Yale University
Clinical trials sponsored by Yale University, explained in plain language.
-
Hormone shots plus vaccine aims to supercharge immune attack on prostate cancer
Disease control Recruiting nowThis phase II trial tests whether adding bipolar androgen therapy (cycles of testosterone) to the standard Sipuleucel-T vaccine can boost the immune response in men with metastatic castration-resistant prostate cancer. About 26 participants will receive both treatments, and resea…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jul 01, 2026 22:00 UTC
-
Could this drug help patients with Hard-to-Treat breast cancer?
Disease control Recruiting nowThis study tests a drug called trastuzumab deruxtecan (T-DXd) in 40 adults with advanced breast cancer that has no HER2 protein (HER2-0). Participants get the drug every 3 weeks. The goal is to see if it shrinks tumors and which patients benefit most.
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Blood test hunts hidden cancer, drug aims to stop it returning
Disease control Recruiting nowThis study tests whether the drug elacestrant can clear traces of cancer DNA found in the blood of people with hormone receptor-positive breast cancer who are at risk of late recurrence. About 50 adults whose blood tests positive for tumor DNA but show no visible spread will take…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Choice over standard care may boost HIV treatment in Justice-Involved groups
Disease control Recruiting nowThis study compares two patient navigation models for people recently involved in the criminal legal system who have substance use disorders. One group gets standard navigation, while the other can choose from a menu of services like in-person clinics, mobile health units, or tel…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Calorie cutting may reverse a key step toward diabetes
Disease control Recruiting nowThis study investigates whether reducing calories to lower fat in the liver and muscles can improve how the body responds to insulin. Researchers will measure changes in insulin sensitivity and fat levels in 250 healthy but insulin-resistant adults with a family history of type 2…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Targeted pill aims to halt recurrent uterine cancer
Disease control Recruiting nowThis phase 2 trial tests the drug afatinib in 50 women with a rare, aggressive uterine cancer (HER2-positive uterine serous carcinoma) that has persisted or returned. Afatinib is a daily pill that blocks a protein driving cancer growth. The main goal is to see if it can keep the …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New study tests Twice-Daily radiation to boost T-Cell attack on lymphoma
Disease control Recruiting nowThis study tests a new way to give radiation before T-cell therapies (CAR T or bispecific antibodies) for people with relapsed or refractory diffuse large B-cell lymphoma. Each participant's tumor is split in half: one side gets once-daily radiation, the other gets twice-daily ra…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Exercise and diet counseling may help cancer patients finish chemo
Disease control Recruiting nowThis study tests whether a program of exercise and nutrition counseling helps women with ovarian or endometrial cancer stick with their chemotherapy plan. About 200 women who are about to start chemotherapy will be randomly assigned to either receive weekly coaching sessions on p…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for rare, painful skin condition: drug trial underway
Disease control Recruiting nowThis study tests if guselkumab can help people with Hailey-Hailey disease, a genetic condition causing painful blisters and sores in skin folds. Ten adults with moderate to severe disease will receive the drug and be monitored for changes in skin severity and quality of life. The…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New strategy: removing tumors one by one after chemo for stomach and pancreatic cancers
Disease control Recruiting nowThis phase 2 trial tests whether a series of procedures to remove cancerous tumors, given one after another, can improve outcomes for people with stage IV foregut cancers (like stomach, pancreas, or bile duct cancer) who have no detectable cancer DNA in their blood after initial …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could less radiation be safer for tough lung tumors?
Disease control Recruiting nowThis study tests a lower-dose radiation regimen for people with non-small cell lung cancer located near the center of the chest. The goal is to see if giving a total of 45 Gray in three sessions can control the tumor while reducing damage to nearby organs like the heart and major…
Phase: PHASE1, PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Bladder wash could cut infections and hospital visits for catheter users
Disease control Recruiting nowThis study tests whether a bladder wash with a low-dose antiseptic (chlorhexidine) during routine catheter changes can reduce urinary tract infections and unplanned healthcare visits. Seventy adults with a long-term suprapubic catheter and a history of UTIs will receive the wash …
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug AB821 enters first human tests for advanced melanoma
Disease control Recruiting nowThis early-stage trial is testing a new drug called AB821 in 50 adults with advanced melanoma or other solid tumors that respond to immune therapies. The main goal is to check safety and find the right dose. Participants receive AB821 by IV every 2 or 3 weeks for up to two years.
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can surgery after meds keep bladder cancer at bay?
Disease control Recruiting nowThis study looks at whether surgery to remove remaining cancer spots can help people with advanced bladder cancer that has been controlled by drug therapy. About 32 adults whose cancer has not spread widely will receive surgery on the main tumor and any other treatable spots. The…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Digital coach in the ER could boost addiction treatment rates
Disease control Recruiting nowThis study tests a digital tool called EMBED that helps emergency doctors identify patients with opioid use disorder and start them on buprenorphine, a medication that reduces cravings and withdrawal. The tool is built into the electronic health record and guides doctors through …
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Two-Drug combo aims to tackle Hard-to-Treat T-Cell lymphoma
Disease control Recruiting nowThis phase 2 trial is testing whether combining two drugs—pembrolizumab (Keytruda) and brentuximab vedotin (Adcetris)—can shrink tumors in people with a type of T-cell lymphoma that has returned or not responded to at least one prior treatment. The study enrolls adults with CD30-…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Old drug, new hope: DCA may shield brain from low blood sugar in type 1 diabetes
Disease control Recruiting nowThis early-phase study tests whether dichloroacetate (DCA), a drug used safely for decades in a rare metabolic disorder, can improve brain function during low blood sugar (hypoglycemia) in people with type 1 diabetes. Sixteen participants with a history of severe hypoglycemia or …
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can an arthritis drug curb alcohol cravings? new trial aims to find out
Disease control Recruiting nowThis study tests whether the drug apremilast can help people with alcohol use disorder drink less. About 80 adults aged 21-65 will receive either apremilast or a placebo, and researchers will measure how much alcohol they consume during a lab drinking session. The goal is to see …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a common blood thinner protect critically ill kids from catheter clots?
Disease control Recruiting nowThis study tests whether enoxaparin, a blood thinner, can prevent blood clots caused by central venous catheters in critically ill children. Researchers will enroll 258 children up to 17 years old and adjust the dose based on age. The goal is to see if age affects how well the dr…
Phase: PHASE2, PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Yale study tests sleep fix to kick smoking habit
Disease control Recruiting nowThis study tests whether a behavioral sleep intervention combined with the drug varenicline can help heavy smokers quit. Researchers will measure sleep quality, smoking habits, and brain activity in 114 participants. The goal is to see if improving sleep reduces negative emotions…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New therapy combo aims to keep women in opioid recovery
Disease control Recruiting nowThis study tests a stepped care program called PCT+2HOPE for women with opioid use disorder who have also experienced intimate partner violence and PTSD symptoms. The program adds group and individual therapy to standard medication treatment. Researchers will see if it helps wome…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
ER study tests higher buprenorphine dose to boost opioid treatment success
Disease control Recruiting nowThis study tests whether a higher starting dose of buprenorphine in the emergency room helps more people with opioid use disorder engage in treatment within 10 days. It also looks at whether the higher dose reduces cravings, withdrawal symptoms, and use of illicit opioids. The tr…
Phase: PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New study tests which breathing aid works best for heart failure patients coming off ventilators
Disease control Recruiting nowThis study compares two breathing support methods—high-flow nasal cannula (HFNC) and non-invasive ventilation (NIV)—in heart failure patients after their breathing tube is removed. The goal is to see which method better prevents the need for re-insertion of the breathing tube or …
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Old heart drug could be new hope against fatty liver
Disease control Recruiting nowThis study tests whether a low dose of digoxin, a drug normally used for heart problems, can help people with a severe type of fatty liver disease called NASH (also known as MASH). The trial will involve 144 adults with biopsy-confirmed NASH and liver scarring. Participants will …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
BREAST CANCER BREAKTHROUGH? new study lets patients choose chemo-free treatment
Disease control Recruiting nowThis study is for people with a common type of breast cancer (ER-positive, HER2-negative) that has a moderate to high risk of coming back based on tumor size and lymph node involvement, but a low genetic risk score. Instead of chemotherapy after surgery, participants can choose t…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for Hard-to-Treat breast cancer: Two-Drug cocktail shows promise
Disease control Recruiting nowThis study is for people with metastatic triple-negative breast cancer that has not responded to one prior treatment. It tests two combinations of drugs: one with sacituzumab govitecan and nivolumab, and another that adds a third drug, relatlimab. The goal is to see which combina…
Phase: PHASE1, PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New therapy aims to break the cycle of addiction and family violence in fathers
Disease control Recruiting nowThis study tests a program called Fathers for Change (F4C) for 280 fathers who struggle with substance misuse and have been violent toward family. The program aims to help them control emotions, stop substance use, and prevent violence. Researchers compare F4C to standard drug co…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a diabetes drug boost dialysis efficiency for kidney patients?
Disease control Recruiting nowThis study tests if empagliflozin, a diabetes drug, can reduce sugar absorption during peritoneal dialysis in 30 adults with end-stage kidney disease. Participants will receive either the drug or a placebo in a crossover design, followed by an 8-week open-label phase where everyo…
Phase: PHASE4 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New combo therapy aims to fight HPV head and neck cancer
Disease control Recruiting nowThis phase 2 pilot study is testing a new drug called CUE-101, alone or combined with pembrolizumab, in 30 people with newly diagnosed, locally advanced HPV-16 head and neck cancer. The goal is to see if the combination boosts the immune system's ability to fight the cancer befor…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Birth control implant gets a new home: the shoulder blade
Disease control Recruiting nowThis study is testing whether the etonogestrel contraceptive implant can be placed under the skin near the shoulder blade instead of the usual upper arm spot. Researchers will check hormone levels and side effects in 62 women over two years. The goal is to see if this alternative…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a month of pills boost radiation for prostate cancer?
Disease control Recruiting nowThis study tests whether adding a short, 30-day course of the oral hormone drug Relugolix to standard targeted radiation (SBRT) works better than radiation alone for men with intermediate-risk prostate cancer. About 60 men will be randomly assigned to one of the two treatments. T…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a diabetes drug curb alcohol cravings after bariatric surgery?
Disease control Recruiting nowThis small pilot study at Yale tests whether semaglutide (a drug used for diabetes and weight loss) can help people who have had bariatric surgery and now struggle with alcohol use disorder. Ten adults will take the drug for three months and be followed for three more months to s…
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can a blood thinner prevent strokes in brain bleed survivors?
Disease control Recruiting nowThis study compares two medicines—apixaban (a blood thinner) and aspirin—in people who have had a brain bleed (intracerebral hemorrhage) and also have an irregular heartbeat (atrial fibrillation). The goal is to see which drug better prevents future strokes or death. About 700 pa…
Phase: PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study tests if office-based methadone keeps more people in opioid addiction treatment than buprenorphine
Disease control Recruiting nowThis study compares two medications—methadone and buprenorphine—given in a doctor's office to treat opioid use disorder. Researchers want to see which one helps people stay in treatment longer over 168 days. About 600 adults starting a new treatment episode will take part. The go…
Phase: PHASE4 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Doctor-Tailored stent graft aims to tame deadly aortic aneurysms
Disease control Recruiting nowThis study tests a stent graft that doctors modify to fit each patient's unique aneurysm in the chest and abdomen. The goal is to see if this less invasive approach is as safe and effective as traditional open surgery. About 80 people aged 50 and older with large aneurysms will t…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Psychedelic DMT trial aims to curb alcohol addiction
Disease control Recruiting nowThis early-stage study tests whether the psychedelic drug DMT, combined with psychotherapy, can help people with alcohol use disorder. 63 participants will receive either a moderate or low dose of DMT, or a placebo, and their safety and desire to drink will be measured. The goal …
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New therapy for fathers aims to break cycle of family violence
Disease control Recruiting nowThis study tests a therapy called Fathers for Change (F4C) for fathers who have been violent with their partner. The goal is to see if this 18-week program helps fathers control their emotions and communicate better, reducing violence toward partners and children. About 1,080 fat…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug combo aims to reduce surgeries for rare HPV throat condition
Disease control Recruiting nowThis early-phase study tests two cancer drugs—lenvatinib (a daily pill) and pembrolizumab (an IV infusion)—in 20 adults with HPV-related recurrent respiratory papillomatosis (RRP) that has spread to the lungs. The goal is to see if the combination can shrink papillomas and reduce…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New combo therapy aims to fight hard-to-treat lymphoma
Disease control Recruiting nowThis study tests adding the drug mogamulizumab to standard chemotherapy for people with aggressive T-cell lymphoma, a type of blood cancer. About 22 adults with newly diagnosed or returning lymphoma will receive the combination treatment. The goal is to see if more patients achie…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New triple therapy takes on stubborn lung cancer in early trial
Disease control Recruiting nowThis early-phase trial is testing a new oral drug called iadademstat combined with radiation therapy and the immunotherapy atezolizumab in people with extensive-stage small-cell lung cancer that has persisted, returned, or worsened after first-line treatment. The study will enrol…
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Breast pump vs. pitocin: a natural way to induce labor?
Disease control Recruiting nowThis study compares using an electric breast pump (or hand stimulation) to standard oxytocin infusion for inducing labor in nearly 1,000 first-time mothers. The goal is to see if nipple stimulation leads to more spontaneous vaginal deliveries and better experiences for moms and b…
Phase: PHASE4 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a diabetes drug curb heavy drinking in HIV patients?
Disease control Recruiting nowThis pilot study tests whether semaglutide, a drug used for diabetes and weight loss, can help people with HIV reduce their alcohol use. Thirty participants will receive the drug along with support from a pharmacist and psychiatrist. The goal is to see if this approach is feasibl…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Blood pressure breakthrough? yale tests community health worker model
Disease control Recruiting nowThis Yale study tests two ways to help people with high blood pressure: a remote monitoring program alone, or that program plus a community health worker who helps with home monitoring, appointments, and social needs like food or housing. 1,440 participants with elevated blood pr…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo aims to free MDS patients from frequent blood transfusions
Disease control Recruiting nowThis Phase II trial tests whether combining luspatercept and darbepoetin alfa can help people with a certain type of lower-risk myelodysplastic syndrome (MDS) need fewer red blood cell transfusions. The study enrolls 60 adults who currently rely on transfusions. Participants rece…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo therapy aims to help bariatric patients drop weight and kick the habit before surgery
Disease control Recruiting nowThis early-stage study at Yale is testing whether a combination of two medications (naltrexone and bupropion) plus cognitive-behavioral therapy can help people who are considering bariatric surgery lose weight and stop smoking. Twenty participants will receive the treatment for f…
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
E-Cigs vs nicotine pouches: which helps smokers quit best?
Disease control Recruiting nowThis study tests whether e-cigarettes or nicotine pouches help adult smokers reduce their cigarette use. 256 participants who smoke will be given one of these products for 4 weeks, with different flavors and nicotine levels. Researchers will track how many cigarettes they smoke a…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a diabetes pill help heal heart and kidney damage at the same time?
Disease control Recruiting nowThis study tests whether adding an SGLT2 inhibitor (a type of diabetes medicine) to standard hospital care helps people with heart failure who also develop acute kidney injury. Researchers will compare outcomes like survival, need for dialysis, and symptom relief between those wh…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a blood pressure drug curb alcohol cravings? new trial investigates
Disease control Recruiting nowThis Phase 2 trial tests whether guanfacine, a drug used for high blood pressure and ADHD, can help people with alcohol use disorder drink less. Researchers will compare guanfacine to a placebo in 160 men and women, measuring alcohol consumption in lab sessions and during a treat…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Vitamin d trial hopes to ease PCOS symptoms in teen girls
Disease control Recruiting nowThis study tests whether taking vitamin D daily for 6 months can improve menstrual regularity and mood in teenage girls with PCOS who also have low vitamin D levels. Sixty participants will be randomly assigned to receive either vitamin D or a placebo, and neither they nor their …
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a diabetes pill ease swelling in liver patients?
Disease control Recruiting nowThis study tests whether empagliflozin, a diabetes drug, can help people with cirrhosis and ascites (fluid buildup in the belly) get rid of excess salt and water. About 20 adults on stable diuretics will take the drug or a placebo for 14 days. Researchers will measure changes in …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Community health workers take on high blood pressure in nepal
Disease control Recruiting nowThis study tests whether trained community health workers can help people in Nepal prevent and control high blood pressure. Over 3,500 participants with high blood pressure will receive home visits and group counseling from health workers. The goal is to see if this approach lowe…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New antibody-drug combo targets tough cervical cancers in early trial
Disease control Recruiting nowThis study tests a drug called sacituzumab govitecan in 20 people whose cervical cancer has returned or persisted after at least one prior chemotherapy. The drug is an antibody-drug conjugate designed to deliver chemotherapy directly to cancer cells. The main goal is to see how m…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a natural hormone curb heavy drinking? new trial aims to find out
Disease control Recruiting nowThis Phase 2 trial tests whether the hormone pregnenolone can help people with alcohol use disorder drink less heavily. 150 adults aged 18-70 will take either 300 mg of pregnenolone or a placebo daily for 12 weeks. The main goal is to see if more people in the pregnenolone group …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Diabetes drug could shield kidneys in rare disease
Disease control Recruiting nowThis study tests whether the diabetes drug metformin can protect kidney cells in people with a rare kidney disease called FSGS. About 30 adults will receive either metformin or a placebo for 6 months, alongside their usual treatments. The goal is to see if metformin reduces kidne…
Phase: PHASE1, PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Sound waves aimed at liver and nerves could tame diabetes
Disease control Recruiting nowThis early study tests whether delivering focused ultrasound pulses to the liver and a nearby nerve bundle can improve blood sugar control in people with type 2 diabetes. Thirty adults on stable oral diabetes medications will receive the ultrasound treatment. The main goal is to …
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Quick HIV meds may slash stigma for drug users
Disease control Recruiting nowThis study tests whether starting antiretroviral therapy within 7 days of an HIV diagnosis can reduce stigma and improve health outcomes for people who inject drugs. Researchers will develop a rapid-start strategy and pilot it with 135 participants at HIV clinics. The goal is to …
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a pharmacist help people with HIV avoid falls and brain fog? new study aims to find out.
Disease control Recruiting nowThis pilot study tests a program where a clinical pharmacist talks with people with HIV about the risks of drinking alcohol (with or without cannabis) while taking multiple medications, especially those that affect the brain. The goal is to see if this approach can reduce falls a…
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New trial tests whether social support can ease type 1 diabetes burden
Disease control Recruiting nowThis study tests a program called T1CARE, where a community health navigator helps young adults with type 1 diabetes address social needs like housing, food, and healthcare access. 100 participants will be randomly assigned to get the navigator right away or after a wait. The goa…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Vaping cessation pill under trial: varenicline tested on 326 adults
Disease control Recruiting nowThis study tests whether the medication varenicline can help adults quit using e-cigarettes. Researchers will compare varenicline to a placebo in 326 people who vape daily. The main goal is to see if more participants can stop vaping for at least a week by the 12-week mark, with …
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Blood pressure drug shows promise in cutting heavy drinking
Disease control Recruiting nowThis study tests whether prazosin, a blood pressure medicine, can help people with alcohol use disorder who also have withdrawal symptoms drink less heavily. About 150 adults will receive either prazosin or a placebo for 12 weeks, along with weekly counseling. The main goal is to…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Radiation zaps resistant cancer spots, may extend immunotherapy success
Disease control Recruiting nowThis study tests whether precisely targeted radiation can control kidney cancer that has started growing in a few spots while a patient is on immunotherapy. About 30 adults with metastatic renal cell carcinoma will receive radiation to up to 5 progressing tumors and continue thei…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Sound wave device zaps artery calcium, could save limbs
Disease control Recruiting nowThis study is testing a device that uses sound waves to break up calcium buildup in the leg arteries of people with peripheral artery disease. The goal is to improve blood flow, reduce pain, and help people walk better. About 50 participants will be followed for one year to see i…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Lifestyle makeover may boost breast cancer treatment success
Disease control Recruiting nowThis study tests whether a structured nutrition and exercise program can improve the chance of a complete response to pre-surgery chemo-immunotherapy in women with triple-negative breast cancer. About 160 women who are not currently exercising or eating many fruits and vegetables…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Diabetes drug could improve heart failure treatment
Disease control Recruiting nowThis phase 2 trial at Yale University is testing whether the diabetes drug ertugliflozin can help people with chronic heart failure manage fluid buildup better than a standard diuretic (metolazone) or a placebo. Sixty adults on daily diuretics will take one of the three treatment…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New strategy aims to boost addiction treatment and curb HIV in central asia
Disease control Recruiting nowThis study tests a program to expand medication-assisted treatment for opioid addiction in Kazakhstan, Kyrgyzstan, and Tajikistan. Researchers will train local health officials and track how many people start and stay on treatment. The goal is to reduce HIV spread among people wh…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a sleep machine boost stroke recovery?
Disease control Recruiting nowThis study looks at whether using a positive airway pressure (PAP) machine to treat obstructive sleep apnea can help people recover better after an ischemic stroke. About 360 participants who have had a stroke and have moderate to severe sleep apnea will be randomly assigned to r…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 26, 2026 13:36 UTC
-
At-home fingerprick test could replace clinic visits for diabetes screening
Diagnosis Recruiting nowThis study tests whether a self-administered fingerstick glucose tolerance test done at home can accurately measure blood sugar levels compared to the standard clinic-based test. Researchers will enroll 60 people at risk for or recently diagnosed with type 1 diabetes. If accurate…
Sponsor: Yale University • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New eHealth tool aims to cut HIV and opioid risks for Justice-Involved women
Prevention Recruiting nowThis study tests a digital health program to help women involved in the criminal justice system start PrEP (a daily pill to prevent HIV) and get treatment for opioid use disorder. Researchers will compare the program to a simpler decision aid alone. The goal is to reduce stigma a…
Phase: PHASE4 • Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
New tool aims to boost HIV prevention in Women's health clinics
Prevention Recruiting nowThis study tests a decision aid that helps women in sexual and reproductive health clinics decide whether to take PrEP, a daily pill that prevents HIV. The tool will be used during counseling visits. Researchers will see if it increases PrEP use and if it's practical for clinics.…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
Can housing and counseling curb gun violence? new haven study aims to find out
Prevention Recruiting nowThis study tests a community-driven program to reduce gun violence in seven high-risk New Haven neighborhoods. It provides housing financial assistance and financial education to recently incarcerated people and their families, and trains local residents in trauma-informed counse…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Prison vaccine push aims to save lives behind bars
Prevention Recruiting nowThis study aims to reduce COVID-19 illness and death among people who live or work in prisons. Researchers will test different ways to encourage COVID-19 vaccination in Pennsylvania prisons, involving over 37,000 participants. The goal is to find what works best to increase vacci…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
AI coach app aims to boost diet, exercise, and sleep in adults at risk
Symptom relief Recruiting nowThis study tests whether the Thrive AI Health app can help adults with type 2 diabetes or overweight improve their daily habits like diet, exercise, and sleep. About 20 participants will either use the app or not, and researchers will compare changes over time. The app uses artif…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Hospital patients may soon control their own pain meds
Symptom relief Recruiting nowThis pilot study tests if patients recovering from shoulder surgery can safely and effectively give themselves liquid acetaminophen (Tylenol) using a pump, instead of waiting for a nurse to bring pills. About 24 adults will be enrolled, and researchers will measure how many agree…
Phase: PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New LGBTQ-Affirmative therapy aims to curb heavy drinking in queer women
Symptom relief Recruiting nowThis study tests a 10-session LGBTQ-affirmative cognitive behavioral therapy (CBT) delivered via telehealth to sexual minority women who drink heavily and have anxiety or depression. Researchers will compare it to standard LGBTQ-affirmative therapy to see if it better reduces hea…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New app aims to ease cancer distress
Symptom relief Recruiting nowThis study tests whether a mobile app called Tools for Coping with Cancer can help people with a history of cancer reduce distress and improve mood and quality of life. About 50 adults who have had cancer will use the app at home for 8 weeks and fill out questionnaires about thei…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could light therapy ease nerve pain from childhood cancer treatment?
Symptom relief Recruiting nowThis study tests whether a six-week at-home light therapy program is practical and helpful for childhood cancer survivors who have nerve pain or numbness from chemotherapy. Twenty survivors aged 5 and older will use a light therapy device on their symptoms for 15 minutes, three d…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Beat the blues: drumming circles tested for Alzheimer's pain and stress
Symptom relief Recruiting nowThis study explores whether group drumming or music listening can improve pain, stress, and brain function in people with early Alzheimer's, mild dementia, or mild cognitive impairment, as well as their caregivers. Over 8 weeks, 60 participants will attend weekly sessions while r…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Could a pill help heavy drinkers cut back? new trial tests mavoglurant
Symptom relief Recruiting nowThis early-stage study tests whether mavoglurant, a drug taken as a pill, can reduce alcohol cravings and drinking in people who drink heavily. Researchers will give the drug or a placebo to 63 adults with Alcohol Use Disorder and measure how much they drink and crave alcohol. Th…
Phase: PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Brain training boosts therapy for BPD?
Symptom relief Recruiting nowThis study tests whether a special brain training technique, called mindfulness-based neurofeedback, can help adults with borderline personality disorder (BPD) get more out of their regular talk therapy. Researchers will use real-time brain scans to help participants learn to con…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Brain training shows promise for tic control in teens
Symptom relief Recruiting nowThis study tests whether real-time fMRI neurofeedback can help teens aged 10-16 with Tourette Syndrome reduce their tics. Participants learn to control activity in a brain region linked to tics by watching their own brain activity on a screen. The trial compares this to a control…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New drug offers hope for breast cancer patients suffering from hot flashes
Symptom relief Recruiting nowThis study tests a drug called fezolinetant to see if it can reduce hot flashes in women who have had breast cancer and are taking hormone therapy. About 92 women will be randomly assigned to receive either fezolinetant or a placebo daily for 12 weeks. The main goal is to measure…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Sleep apnea study tests pill to boost CPAP use and brain power
Symptom relief Recruiting nowThis study tests whether a sleep medication called eszopiclone can help people with obstructive sleep apnea use their CPAP machine more consistently and improve their thinking skills. About 250 adults with a new sleep apnea diagnosis will receive either eszopiclone or a placebo f…
Phase: PHASE3 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can a skin cell spray help scars blend in? new study aims to find out
Symptom relief Recruiting nowThis study tests whether using RECELL® — a device that creates a spray from a patient's own skin cells — can improve skin color matching after head and neck reconstructive surgery. Twenty adults who need this surgery will receive the treatment, and their color match, healing, and…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Wellness app aims to ease anxiety and boost mood – but does it work?
Symptom relief Recruiting nowResearchers at Yale University are testing whether a smartphone app called Caravan Wellness can improve quality of life, reduce stress, and ease symptoms of anxiety and depression. The app offers short mindfulness and light exercise modules like yoga and meditation. The study wil…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can an app curb gambling addiction? new study seeks answers
Symptom relief Recruiting nowThis study tests whether a smartphone app called Change4Better (C4B) can help reduce problem gambling compared to standard treatment alone. About 128 adults who gamble and want help will use the app for 6 months. Researchers will track changes in gambling symptoms and how often p…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New ICU sleep therapy aims to reset body clocks in critical illness
Symptom relief Recruiting nowThis study tests a combination of sleep-promoting and circadian-aligning treatments (a "sleep chronobundle") in 160 critically ill ICU patients. The goal is to see if realigning the body's internal clock can improve sleep quality and metabolism. Participants will receive the bund…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Ketamine showdown: IV drip vs nasal spray for depression
Symptom relief Recruiting nowThis study compares two forms of ketamine for people with depression that hasn't improved with other treatments. One is given through an IV drip, the other as a nasal spray. Researchers want to see which works better, is more acceptable to patients, and has fewer side effects. Ab…
Phase: PHASE3 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
CBD could help ease pain and cravings in opioid recovery
Symptom relief Recruiting nowThis early-phase study at Yale tests whether cannabidiol (CBD) is safe and can reduce pain and opioid cravings in 34 adults with opioid use disorder and chronic pain. Participants are already on methadone or buprenorphine and will receive different doses of CBD or a placebo in a …
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Could a tiny ear device tame IBS pain? new trial recruits young adults
Symptom relief Recruiting nowThis study tests whether a small, home-use device that gently stimulates a nerve in the ear can help young adults (ages 18-29) manage pain and other symptoms of irritable bowel syndrome (IBS). Eighty participants will use either the active device or a sham (inactive) version twic…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Which heart drug works best for seniors with multiple ailments? new trial aims to find out
Symptom relief Recruiting nowThis study compares two common types of heart medications—beta-blockers and calcium channel blockers—in adults aged 65 and older who have stable angina (chest pain) and at least two other chronic conditions. The goal is to see which drug works better and is easier to tolerate, fo…
Phase: PHASE4 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New hand device could help stroke patients move again
Symptom relief Recruiting nowThis study tests a handheld device called PoRI that moves the hand for people who had a stroke within the past 2 days to 2 months. It compares the device to standard hand therapy in 12 participants. The goal is to see if the device improves hand function, reduces pain, and is eas…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can a Cannabis-Derived drug ease pain without raising opioid risks?
Symptom relief Recruiting nowThis early-phase trial at Yale tests whether dronabinol (Marinol), a synthetic form of THC, can reduce pain sensitivity and improve attention and mood in 36 adults with opioid use disorder who are stable on methadone or buprenorphine. Participants receive either 2.5 mg, 5 mg of d…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Magic mushroom compound tested for hard-to-treat mental health struggles
Symptom relief Recruiting nowThis early-stage study at Yale is testing whether a single 25 mg dose of psilocybin is safe and tolerable for people whose daily life is impaired by mood, anxiety, trauma, or addiction symptoms. Fifty participants will receive the drug openly (everyone knows they get it) and be f…
Phase: PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New back pain procedure under the microscope: who gets the best relief?
Symptom relief Recruiting nowThis study follows 200 people with chronic low back pain who are scheduled for a procedure called basivertebral nerve ablation. The goal is to see how much pain and function improve over two years and to figure out which patients benefit the most. Participants will answer weekly …
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Quick mind training may curb binge drinking in young adults
Symptom relief Recruiting nowThis study tests whether brief training in mindfulness or cognitive-behavioral techniques can reduce heavy drinking in young adults aged 18-26. Participants will complete 1-4 training sessions and report their drinking via smartphone. The goal is to see if these techniques help p…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Can mindfulness fix sleep and cut heart risk in black women?
Symptom relief Recruiting nowThis study tests a 6-week mindfulness-based program designed to improve sleep and reduce stress in Black women with insomnia. Researchers will enroll 340 women and track changes in sleep quality, stress levels, and how acceptable and feasible the program is. The goal is to see if…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Music mindfulness study aims to ease stress in african descent communities
Symptom relief Recruiting nowThis study compares music-backed mindfulness meditation to meditation alone for reducing stress and anxiety in people of African descent. 70 participants with anxiety or depression will join virtual sessions. The goal is to see if adding music makes stress management more effecti…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can a mindfulness app help young adults with diabetes?
Symptom relief Recruiting nowThis study tests a mindfulness app called Calm Health in 10 young adults (ages 18-30) with type 1 diabetes or similar conditions. Participants use the app to track mindfulness, blood sugar, stress, and sleep, and get personalized feedback. The goal is to see if the app is easy to…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Brain zaps may boost social skills in autism
Symptom relief Recruiting nowThis study tests whether a noninvasive brain stimulation technique called rTMS can improve social abilities in adults with autism. Researchers will measure brain responses and eye gaze patterns before and after treatment. The goal is to see if this approach can ease core social c…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Brain zaps for voice relief: new trial targets laryngeal dystonia
Symptom relief Recruiting nowThis early study tests whether a non-invasive brain stimulation technique called tDCS can improve voice quality in people with laryngeal dystonia (spasmodic dysphonia). Ten participants will receive active, sham, and no stimulation to compare effects. The goal is to see if target…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Balloon or dilators? new study seeks better way to prepare for abortion procedure
Symptom relief Recruiting nowThis study compares two FDA-cleared devices used to soften and open the cervix before a dilation and evacuation (D&E) procedure in the second trimester. One device is a balloon catheter, the other is a set of absorbent rods (osmotic dilators). The goal is to see which method work…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Could a Once-Daily pill curb the urge to pull hair?
Symptom relief Recruiting nowThis study tests whether a daily medication called valbenazine can reduce hair-pulling in adults with trichotillomania. About 20 people will receive either the drug or a placebo for 12 weeks, then everyone gets the drug for another 12 weeks. The goal is to see if the drug safely …
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Veterans' headache study seeks best nerve block dose
Symptom relief Recruiting nowThis study is for veterans with long-term headaches after a head injury. It compares three different doses of a numbing medicine injected near a nerve in the scalp. Each participant will try all three doses, one week apart, to see which works best and feels most comfortable. The …
Phase: PHASE1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can an app kick the vaping habit? new trial tests digital therapy for teens
Symptom relief Recruiting nowThis study tests whether a smartphone app called Kick-Nic! can help high school students (ages 13-19) quit vaping. About 306 participants who want to quit will either use the app or visit a standard quit-vaping website for 8 weeks. Researchers will check if they've stopped vaping…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could ecstasy help people with borderline personality disorder connect better?
Symptom relief Recruiting nowThis small study at Yale is testing whether a single dose of MDMA (the drug in ecstasy) can improve social cognition—like reading emotions and feeling sociable—in adults with borderline personality disorder. Ten participants will take the drug and complete tasks and surveys. It's…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Can a website replace the therapist? new trial tests Video-Based pelvic floor exercises
Symptom relief Recruiting nowThis study is testing whether a remote, video-based pelvic floor muscle therapy program is easy to use and practical for patients with pelvic floor disorders like prolapse, incontinence, or bowel issues. Twenty participants will follow an 8-week online course at home. The main go…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can therapy heal family rejection? new trial targets LGBTQ+ mental health
Symptom relief Recruiting nowThis study tests two types of talk therapy—individual LGBTQ-affirmative CBT and family-based therapy—delivered online to LGBTQ+ adults (age 20+) who have nonaccepting parents. The goal is to see if these therapies reduce depression and anxiety symptoms. The trial is currently rec…
Phase: PHASE3 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can cannabis compounds help tame opioid cravings and chronic pain?
Symptom relief Recruiting nowThis phase 2 study at Yale University is testing whether a combination of THC and CBD can reduce both pain sensitivity and opioid cravings in people who have opioid use disorder and chronic low back pain. The 147 participants are all on methadone therapy and will receive either a…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Free CGM sensors could transform diabetes care for underserved patients
Symptom relief Recruiting nowThis study provides free continuous glucose monitors (CGMs) to 17 adults with poorly controlled type 2 diabetes. Researchers will track changes in blood sugar levels and quality of life over time. The goal is to see if easier access to CGM technology helps patients manage their d…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Brain training may help curb food cravings
Symptom relief Recruiting nowThis study tests whether people with overweight or obesity and high food cravings can learn to change their brain's response to food cues using real-time neurofeedback. Participants will try to control a thermometer-like display reflecting their brain activity while viewing food …
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Sitz baths tested as pain relief after pelvic surgery
Symptom relief Recruiting nowThis study tests whether taking warm water sitz baths for 10 minutes each night for a week can reduce pain after pelvic organ prolapse repair. 112 women will be randomly assigned to sitz baths or standard care. The main goal is to measure pain intensity one week after surgery usi…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Ancient chinese exercise tested for back pain relief in seniors
Symptom relief Recruiting nowThis study tests a gentle exercise program combining Baduanjin (a traditional Chinese mind-body practice) with resistance training for older adults with osteoporosis and a slipped disc in the lower back. Researchers want to see if it can reduce pain, improve muscle strength, and …
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Can treating parents help teens with anxiety?
Symptom relief Recruiting nowThis study tests whether a parent-only therapy (SPACE) can reduce anxiety in teens, compared to a parent education support group. About 108 adolescents with anxiety disorders will participate. Parents attend 12 weekly sessions, and researchers measure teen anxiety symptoms before…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New app aims to get type 1 diabetes patients moving without fear
Symptom relief Recruiting nowThis study tests a mobile app that gives personalized exercise coaching and feedback on blood sugar, sleep, and mood to help middle-aged adults with type 1 diabetes exercise more. Participants get a free Garmin smartwatch and program membership. The goal is to see if the app help…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New program aims to ease pain and curb opioid misuse for veterans
Symptom relief Recruiting nowThis study tests whether extra support for case managers helps veterans leaving the military better manage pain and reduce risky substance use. About 1800 veterans will take part. The program focuses on non-drug pain treatments and counseling.
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Sound waves may stop stubborn seizures in ICU patients
Symptom relief Recruiting nowThis study tests whether a gentle, non-invasive ultrasound treatment can reduce or stop seizure activity in people with a severe type of ongoing seizure called status epilepticus that hasn't improved with standard medications. Ten participants in the ICU will receive a 10-minute …
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Could a diabetes pill help you breathe better at night?
Symptom relief Recruiting nowThis study tests whether bexagliflozin, a drug used for diabetes, can reduce the severity of obstructive sleep apnea in overweight or obese adults. Over 6 months, participants will take either the drug or a placebo and undergo sleep tests and body scans. The goal is to see if the…
Phase: PHASE4 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 26, 2026 16:45 UTC
-
Phone app aims to speed recovery after hip, knee, and spine surgery
Symptom relief Recruiting nowThis study tests whether a mobile app can help patients do simple in-bed exercises after orthopedic surgery for spine, hip, or knee problems. About 100 participants will use the app or receive usual care. Researchers will measure how well patients recover their ability to move an…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 26, 2026 13:14 UTC
-
Maine cancer patients get free groceries and coaching in new study
Symptom relief Recruiting nowThis study is testing whether giving cancer patients in Maine free, medically tailored groceries plus nutrition counseling can improve their diet and well-being. One hundred adults with any stage or type of cancer will be split into three groups: one gets groceries and counseling…
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 26, 2026 13:00 UTC
-
Building a database to unlock wilson disease mysteries
Knowledge-focused Recruiting nowThis study creates a registry for people diagnosed with Wilson disease, a rare genetic condition that causes copper buildup in the body. Researchers will collect medical data and biological samples over time to help future studies improve diagnosis and treatment monitoring. The g…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Personalized chemo test aims to improve treatment for advanced abdominal cancers
Knowledge-focused Recruiting nowThis study tests a new method called mass-based response testing (MRT) to help doctors choose the best chemotherapy drugs for patients with advanced appendix or colorectal cancer that has spread to the abdomen. The MRT device analyzes live tumor cells to see which drugs work best…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
What do seniors need after ICU? new study aims to find out
Knowledge-focused Recruiting nowThis study follows 350 older adults (65+) who return home after an ICU stay to see what help they still need with daily activities. Researchers will track disabilities, hospital readmissions, and deaths over six months. The goal is to identify gaps in care so better programs can …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
E-Cig coolants may boost appeal – study investigates
Knowledge-focused Recruiting nowThis study looks at how cooling ingredients like WS-3 and menthol in e-cigarettes affect how much people like them and find them addictive. Researchers will have 66 adult e-cigarette users try different e-liquid mixtures and report their feelings of liking, craving, and harshness…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Yale researchers dive into lymph nodes to unlock kidney cancer secrets
Knowledge-focused Recruiting nowThis study looks at the immune cells in the lymph nodes near kidney tumors to learn how the body fights the cancer. Researchers will analyze tissue samples from 10 adult kidney cancer patients to find clues about why some treatments work and others don't. The goal is to discover …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Brain chemistry clue may explain why heavy drinkers feel stressed
Knowledge-focused Recruiting nowThis study investigates how acetate, a substance produced when the body breaks down alcohol, is used by the brain in heavy drinkers. Researchers will use a special imaging technique to track acetate metabolism and measure stress hormone levels. The goal is to understand the link …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Brain scans may predict opioid relapse risk
Knowledge-focused Recruiting nowThis observational study at Yale University aims to understand how people with opioid use disorder (OUD) learn to avoid pain compared to healthy individuals. About 180 participants will perform a learning task inside an fMRI scanner to measure brain activity. Those with OUD will …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists probe Brain's hidden alarm system in epilepsy patients
Knowledge-focused Recruiting nowThis study looks at how the brain's arousal systems work when we see, hear, or feel things. Researchers will use brain scans, eye tracking, and electrical recordings in healthy volunteers and epilepsy patients. The goal is to understand shared brain pathways that help us stay ale…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Yale scientists seek Nicotine's 'Addiction Threshold' in smokers
Knowledge-focused Recruiting nowThis study aims to find the smallest amount of nicotine that smokers find rewarding or addictive. Researchers will test different nicotine doses in 45 adult smokers to see which dose they can identify and prefer. The goal is to better understand how addiction develops, which coul…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Scientists zap brains to unlock secrets of social connection
Knowledge-focused Recruiting nowThis study at Yale University investigates how two people's brains synchronize during live face-to-face interactions. Researchers will use brain stimulation (TMS and tDCS) along with EEG and eye tracking to measure changes in brain activity and social behaviors. The goal is to be…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Zapping the brain to rewire OCD fear circuits
Knowledge-focused Recruiting nowThis study at Yale investigates how people with OCD process fear and safety signals in the brain. Researchers will use mild electrical stimulation (tDCS) to see if it can improve fear extinction learning, which is key to exposure therapy. 180 adults with OCD will undergo brain sc…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists to scan brains of people with PTSD and alcohol addiction
Knowledge-focused Recruiting nowThis study uses a special PET scan tracer to measure a brain protein called PDE4B in people with PTSD or alcohol use disorder. Researchers want to see if levels of this protein differ from healthy individuals. The study involves 160 adults aged 18 to 70 and does not offer treatme…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Can peer mentors bridge the mental health gap for latinos?
Knowledge-focused Recruiting nowThis study is testing whether a culturally responsive, peer-delivered motivational interviewing program can help Latinos with serious mental illness engage in mental health treatment. Thirty participants who are not currently in treatment will receive six weekly one-hour coaching…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Could a womb shape condition raise cancer risk? new study investigates
Knowledge-focused Recruiting nowThis study looks at women born with an irregularly shaped uterus (congenital uterine anomaly) to see if they have higher chances of certain cancers, like breast or ovarian cancer. Researchers will also try to find genetic or environmental reasons for the condition. About 300 wome…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Brain scans reveal Loneliness's hidden toll on seniors
Knowledge-focused Recruiting nowThis study looks at how feeling disconnected from others affects the brain in people aged 55 and older. Researchers will use brain scans like MRI and PET to measure brain activity and connections. The goal is to understand the link between social isolation and suicide risk in lat…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Massive registry launches to track general anesthesia in C-Sections
Knowledge-focused Recruiting nowThis study is a large registry that collects information from hospitals across the U.S. on pregnant women who receive general anesthesia during a cesarean delivery. Researchers aim to understand why general anesthesia is used, how it is managed, and what outcomes occur for both m…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Phosphate therapy's hidden toll on aging bodies revealed
Knowledge-focused Recruiting nowThis study looks at how long-term phosphate therapy affects the kidneys, blood vessels, and heart in people with two rare bone disorders: X-linked hypophosphatemia (XLH) and hereditary hypophosphatemic rickets with hypercalciuria (HHRH). Researchers will measure hormone levels an…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Brain scans may reveal windows for opioid recovery
Knowledge-focused Recruiting nowThis study uses repeated fMRI brain scans to track changes in people receiving medication for opioid use disorder. Ten participants will be scanned every two weeks for six months while performing tasks. The goal is to understand how the brain changes during recovery and identify …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Scientists probe Brain's speech learning secrets
Knowledge-focused Recruiting nowThis study aims to understand how the brain learns and remembers new ways of speaking. Researchers will use brain scans (fMRI) and magnetic pulses (TMS) to see which brain areas are involved. 50 healthy, right-handed, fluent English speakers with normal hearing will participate. …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Gut check: could your intestines hold clues to Parkinson's and MS?
Knowledge-focused Recruiting nowThis study looks at immune cells in the gut to understand how they might be linked to multiple sclerosis, Parkinson's disease, and REM sleep behavior disorder. Researchers will collect colon tissue samples from 100 adults during colonoscopy. The goal is to map these cells and the…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Could a diabetes pill boost chemo response in breast cancer? new study investigates.
Knowledge-focused Recruiting nowThis early-phase study looks at whether adding dapagliflozin, a diabetes drug, to standard chemotherapy changes insulin-related markers in the blood. It involves 20 women with early-stage HER2-negative breast cancer who also have high insulin levels. The goal is to gather safety …
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Heart failure drug resistance: scientists test new combinations
Knowledge-focused Recruiting nowThis study looks at why some people with heart failure don't get rid of excess fluid with standard water pills (diuretics). Researchers will test adding two other types of diuretics—bendroflumethiazide and amiloride—to see if they improve the body's response. Fifty adults with he…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Heart failure mystery: why do water pills fail some patients?
Knowledge-focused Recruiting nowThis study aims to understand why some heart failure patients do not respond well to diuretics (water pills). Researchers will give 75 heart failure patients different doses of a diuretic called bumetanide and measure how their kidneys handle sodium. The goal is to identify biolo…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
500 families join quest to unlock genetic secrets of miscarriage
Knowledge-focused Recruiting nowThis study aims to discover the genetic reasons behind recurrent pregnancy loss (RPL) by analyzing DNA from parents and pregnancy tissue. Researchers at Yale University will enroll 500 women who have had multiple pregnancy losses. The goal is to identify genetic markers that pred…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Yale study investigates diuretic resistance in heart failure
Knowledge-focused Recruiting nowThis study looks at why some people with heart failure don't respond well to diuretics (water pills). Researchers will give 50 participants either ammonium chloride or a placebo, along with standard diuretics, to see how it affects kidney function. The goal is to understand the b…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New lab model aims to speed up alcoholism drug screening
Knowledge-focused Recruiting nowThis study aims to create a lab-based test to help screen medications for Alcohol Use Disorder (AUD). Researchers will observe how 90 adults with AUD resist drinking in a controlled setting. The goal is to develop a reliable method to test new treatments, not to provide direct th…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Yale study to uncover hidden link between blood pressure swings and stroke recovery
Knowledge-focused Recruiting nowThis observational study at Yale University will follow 150 people who have had an ischemic stroke to see how changes in blood pressure affect their recovery. Researchers will use brain scans and thinking tests to understand the connection. The goal is to find better ways to mana…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Massive hip surgery showdown: preservation vs. replacement
Knowledge-focused Recruiting nowThis study will follow 10,000 people who need hip surgery to compare two approaches: hip preservation surgery (which tries to keep the natural hip joint) and total hip replacement (which replaces the joint). The goal is to see which surgery leads to better pain relief, function, …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Tiny study probes hidden sodium storage in kidney patients
Knowledge-focused Recruiting nowThis study at Yale University is testing whether the body can store sodium without holding onto extra water, a concept called 'water-free sodium storage.' Ten adults on peritoneal dialysis with heart failure will receive either a special dextrose solution or standard dialysis flu…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Liver clinic program aims to tackle alcohol use disorder
Knowledge-focused Recruiting nowThis study tests a new program designed to help liver doctors provide treatment for alcohol use disorder. The program includes education for doctors and patients, decision support tools, and feedback on performance. Researchers want to see if this approach is practical and accept…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can a 35-Minute exercise test predict surgery risks in seniors?
Knowledge-focused Recruiting nowThis study looks at whether a quick, low-intensity exercise test called SHAPE™ can help doctors assess fitness in adults over 60 before moderate- to high-risk surgery. About 371 participants will take the test and answer questions about their activity level. Researchers will then…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Yale study tests if teaching pregnant women about local foods improves health
Knowledge-focused Recruiting nowThis study tests a nutrition education program for first-time pregnant women in northern Ghana. The program teaches women how to eat a wider variety of local foods, get more protein and iron, and gain healthy weight. Researchers will measure changes in health knowledge, diet, and…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Ketamine's Suicide-Fighting secret under the microscope
Knowledge-focused Recruiting nowThis study at Yale University is testing whether blocking a specific brain receptor (AMPA) stops ketamine from reducing suicidal thoughts. Thirty adults with depression, bipolar disorder, or PTSD who have current suicidal thoughts will receive either perampanel (an AMPA blocker) …
Phase: PHASE2 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Brain scans reveal clues to Ketamine's Depression-Fighting power
Knowledge-focused Recruiting nowThis study looks at how ketamine works in the brain to relieve depression. Researchers are giving people with hard-to-treat depression either a placebo or a drug called perampanel before a dose of ketamine. They will use brain scans to see if blocking certain brain receptors chan…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Psychedelics rewire Brain's learning? yale study investigates
Knowledge-focused Recruiting nowThis observational study at Yale University is recruiting 200 people who are already taking part in another trial where they may receive a serotonergic psychedelic (like psilocybin or LSD) or a placebo. Researchers want to understand how these substances change the brain's inform…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Scientists scan brains to uncover cannabinoid receptor secrets in mental illness and addiction
Knowledge-focused Recruiting nowThis study uses a special PET scan tracer called [11-C]OMAR to measure cannabinoid receptors in the brain. Researchers will compare healthy volunteers to people with schizophrenia, cannabis dependence, PTSD, opioid use disorder, and other conditions. The goal is to understand how…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Brain scans reveal how opioid addiction affects key receptors
Knowledge-focused Recruiting nowThis study uses brain scans to compare a specific receptor (CB1) in people with opioid use disorder who are on methadone treatment versus healthy volunteers. The goal is to understand how the endocannabinoid system works differently in addiction. No new treatment is tested; it is…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Stress test: scientists probe pain and hormones in HIV, cannabis, and depression
Knowledge-focused Recruiting nowThis study looks at how stress impacts pain, hormone levels, and mood in 120 people with and without HIV, cannabis use disorder, and depression. Participants will complete two sessions of a pain stress task and provide blood samples to measure cortisol and other stress hormones. …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
THC study investigates gender differences in getting high
Knowledge-focused Recruiting nowThis study looks at how the active ingredient in cannabis, THC, affects men and women differently. Researchers will give THC to 100 healthy adults who have used cannabis before and measure their feelings of being 'high' and memory performance. The goal is to understand why men an…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Short Pre-Surgery exercise test may spot hidden risks
Knowledge-focused Recruiting nowThis study is testing whether a short exercise test done before surgery can help predict complications in adults over 45 having moderate- to high-risk operations. Researchers will collect data from routine care and exercise tests to see if results link to heart, lung, or other pr…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New brain scan tracer could shed light on brain chemistry
Knowledge-focused Recruiting nowThis study is testing a new radioactive tracer called [18F]GATT-44 to see how well it can image GABA transporters in the brain using PET scans. The goal is to understand how the tracer moves through the body and binds to brain cells, and to measure the radiation exposure. About 3…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Brain zapping study seeks to rewire social circuits in autism
Knowledge-focused Recruiting nowThis study looks at whether a non-invasive brain stimulation technique called TMS can change brain activity related to understanding others' thoughts (mentalizing) in young adults with autism. Researchers will compare brain scans before and after stimulation in 80 participants, i…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Peer power: uganda study tests if community counselors boost TB-HIV outcomes
Knowledge-focused Recruiting nowThis study in Uganda tests whether trained peer counselors can help people with tuberculosis (TB) and HIV stay on track with their medications. About 1,920 adults will take part, and researchers will compare treatment success rates between clinics using peer-led education and tho…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Brain scans reveal what happens when heavy cannabis users stop
Knowledge-focused Recruiting nowThis study looks at brain changes in people who use cannabis heavily and want to quit. Researchers will use brain scans to measure a protein linked to brain cell connections, both before and after at least 4 weeks of not using cannabis. They will also test memory to see if brain …
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Brain scan study seeks root of depression in Parkinson's
Knowledge-focused Recruiting nowThis study aims to find the brain areas responsible for depression in people with Parkinson's disease. Researchers will use brain scans to compare 120 participants aged 40-80 who have both conditions. The goal is to identify targets for future treatments, not to test a new therap…
Phase: PHASE2 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Yale launches massive heart failure registry to monitor Real-World care
Knowledge-focused Recruiting nowThis study creates a live registry of up to 40,000 heart failure patients across the Yale New Haven Health System. Researchers will track hospitalizations and use of recommended therapies like beta blockers and ACE inhibitors. The goal is to monitor and improve heart failure care…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Pausing wilson disease drugs for better monitoring?
Knowledge-focused Recruiting nowThis study looks at whether briefly stopping Wilson disease medication can give a clearer picture of copper levels in the body. Researchers will monitor 30 stable patients for 4 days off treatment, measuring urine copper and blood markers. The goal is to find a better way to trac…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Study probes Cannabis' impact on aging brains
Knowledge-focused Recruiting nowThis study looks at how cannabis use changes brain connections in adults aged 50 and older. Researchers will use a special PET scan to measure synaptic density in the hippocampus, a key memory area. The goal is to understand, not treat, so no drug is given—just one scan. Results …
Phase: PHASE1, PHASE2 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Scientists investigate THC effects in seniors for pain relief
Knowledge-focused Recruiting nowThis study looks at how THC, the main active part of cannabis, affects older adults aged 65 and up. Researchers want to understand how the body processes THC when taken as a pill or inhaled, and how it impacts pain and the risk of misuse. Twenty healthy volunteers with past canna…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
VR headset helps young cancer patients understand their treatment
Knowledge-focused Recruiting nowThis study is testing a virtual reality (VR) program called Life at 100.4 to help teens and young adults with cancer, along with their caregivers, learn about their diagnosis and treatment in an immersive way. About 45 participants will use the VR tool, and researchers will measu…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Yale scientists uncover how we learn to speak – and never forget
Knowledge-focused Recruiting nowThis study explores how the brain learns and remembers speech movements. Researchers will have 330 healthy adults say words while hearing their own voice slightly altered through headphones. The goal is to understand which brain areas help us adapt and retain new speech patterns,…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Brain study aims to unlock secrets of speech learning
Knowledge-focused Recruiting nowThis study looks at how the brain learns and remembers new ways of speaking. Researchers will use brain stimulation and brain scans in 160 healthy adults to see which brain areas are important for speech motor learning and retention. The goal is to better understand the basic sci…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Heart failure drug flaw revealed in new study
Knowledge-focused Recruiting nowThis study looks at why standard heart failure medications may not fully block a hormone called aldosterone. Researchers will give 20 adults with stable heart failure either a placebo or the drug spironolactone, then measure how the body handles salt and water. The goal is to und…
Phase: PHASE4 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Scientists probe Brain's speech learning secrets
Knowledge-focused Recruiting nowThis study aims to understand which parts of the brain help us learn and remember new ways of speaking. Researchers will use brain scans and magnetic pulses to observe brain activity in 120 healthy adults. The goal is to learn more about how speech motor learning works, not to te…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New imaging tool could better track painful calcium buildup in scleroderma
Knowledge-focused Recruiting nowThis study aims to develop a better way to measure calcium deposits under the skin in people with scleroderma. Researchers will use CT scans and special software to see if these measurements match how patients report their symptoms. About 56 adults with scleroderma and calcium de…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
5,000 patients join Yale's quest to crack rheumatic disease mysteries
Knowledge-focused Recruiting nowThis study is building a large registry and biorepository of 5,000 adults with various rheumatic diseases like rheumatoid arthritis, lupus, and scleroderma. Researchers at Yale University will collect medical data and biological samples over time to better understand these condit…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Music and mindfulness: a new way to ease stress in black communities?
Knowledge-focused Recruiting nowThis study tests whether a virtual, community-based program combining music and mindfulness can help People of African Descent manage stress, anxiety, and depression during COVID-19. Researchers will measure brain activity and feelings of social connection in 48 participants as t…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Text or portal: which gets parents access to Kids' health records faster?
Knowledge-focused Recruiting nowThis study looks at the best way to help parents get online access to their child's medical records. About 5,200 parents will either get a text, a message through their own patient portal, or no message at all. Researchers will then compare which group had more parents successful…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New study tracks malaria and HIV drug effects in kids over two years
Knowledge-focused Recruiting nowThis study follows 380 children in Uganda for two years to understand how malaria and HIV treatments interact. Half the children have HIV and half do not. Researchers will measure changes in body weight, blood sugar, and drug levels to find the best ways to treat both infections …
Phase: PHASE4 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Brain scans reveal hidden clues in mental illness
Knowledge-focused Recruiting nowThis study uses a special brain scan (PET) to measure the density of connections between brain cells in people with psychotic disorders (like schizophrenia) or cannabis use disorder, compared to healthy volunteers. The goal is to understand how brain connection changes relate to …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Yale study to uncover how insulin resistance drives high triglycerides
Knowledge-focused Recruiting nowThis study looks at how different types of insulin resistance (in fat or muscle) affect the liver's production of fats called triglycerides. Researchers will measure fat production after a meal, with and without exercise beforehand. The goal is to understand why some people have …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
AI chatbot aims to boost HIV testing among malaysian men
Knowledge-focused Recruiting nowThis study is testing whether an AI-powered chatbot on a smartphone can encourage more men in Malaysia to get tested for HIV. The study will enroll 296 men who have sex with men and have not been tested recently. Participants will use the chatbot and report every 30 days whether …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Bedside brain scans could revolutionize care after cardiac arrest
Knowledge-focused Recruiting nowThis study tests a portable MRI machine to look for brain injury in patients who have had a cardiac arrest. Researchers will scan the brain multiple times over several days to see how injuries change. The goal is to make brain imaging available at hospitals without specialized sc…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Gut bacteria may hold key to Obesity-Related insulin resistance
Knowledge-focused Recruiting nowThis study looks at how the fermentation of food in the gut affects metabolism in young people aged 15–22 with obesity. Researchers will give participants a sugar called lactulose to trigger fermentation and measure changes in fat breakdown and sugar production. The goal is to un…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Heart failure patients: does stress make it worse?
Knowledge-focused Recruiting nowThis study looks at whether acute stress can cause sudden worsening of congestive heart failure. Researchers will monitor 112 heart failure patients who have an implanted device that measures pressure in the lung artery. They will compare pressure readings during stressful and ca…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Nepal pilot aims to stop suicides in remote villages
Knowledge-focused Recruiting nowThis study tests a suicide prevention package (PSuPP) in rural Nepal's primary care clinics. Researchers will train healthcare workers to better identify and support people at risk of suicide. The pilot involves 147 participants and focuses on whether the program is practical and…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Scientists hunt for best spot to spot hidden bleeding
Knowledge-focused Recruiting nowThis study uses a special chamber that creates mild blood-pooling in the legs to safely mimic early blood loss in 120 healthy adults aged 20-45. Researchers will compare signals from different body monitors to see which one best detects the change. The goal is to find a more reli…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New device aims to replace needles for measuring heart vein pressure
Knowledge-focused Recruiting nowThis study tests a new device that measures blood pressure in a neck vein to estimate pressure in the heart's central veins, without needing a catheter. About 40 adults in the cardiac ICU will have both the non-invasive test and the standard invasive measurement to see if the new…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Can a few online exercises boost parental acceptance of LGBTQ+ youth?
Knowledge-focused Recruiting nowThis study is developing and testing two short online writing exercises to help parents in the Southeast US become more accepting of their sexual and gender minority children (ages 15-29). About 129 parents who identify as heterosexual and cisgender and who report some non-accept…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
New registry aims to unlock secrets of rare genetic condition in kids
Knowledge-focused Recruiting nowThis study is creating a registry for children with PTEN Hamartoma Tumor Syndrome (PHTS), a rare genetic condition that increases cancer risk. Researchers will follow 100 participants for 3 years to link genetic changes with health outcomes. The goal is to develop better monitori…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Tiny yale study probes blood flow cuffs for ACL rehab
Knowledge-focused Recruiting nowThis study tests whether using a special cuff to partly block blood flow during exercise can improve recovery after ACL reconstruction. Twenty adults will have two training sessions—one with the cuff inflated and one without—so researchers can compare changes in immune cells and …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New registry aims to unlock secrets of myasthenia gravis
Knowledge-focused Recruiting nowThis study is creating a registry of 800 adults with myasthenia gravis at Yale University. Participants donate blood and stool samples, which will be used for future research to better understand the disease. The goal is to collect data and samples to support many research projec…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Yale launches massive hunt for MS early warning signs
Knowledge-focused Recruiting nowThis study looks for early clues that someone might develop multiple sclerosis (MS) before they have any symptoms. Researchers will collect health data and samples from 1,000 adults who have risk factors like a family history of MS or past Epstein-Barr virus infection. The goal i…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Rewiring motherhood: brain study targets opioid recovery in new moms
Knowledge-focused Recruiting nowThis study looks at whether a 12-session parenting program can change brain activity in mothers recovering from opioid use disorder. Researchers will use EEG to measure brain responses to baby faces and cries before and after the program. The goal is to see if supporting the moth…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Can brain wiring predict opioid relapse? yale launches 240-Person study
Knowledge-focused Recruiting nowThis study uses brain scans to understand why some people relapse to opioid use during treatment. Researchers at Yale will follow 240 adults recently started on methadone or buprenorphine, tracking their brain connectivity and drug use for six months. The goal is to identify patt…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Brain scans reveal clues to alcoholism risk in Family-History study
Knowledge-focused Recruiting nowThis early-phase study at Yale University is investigating how the drug mavoglurant affects brain activity in people with a family history of alcoholism. Researchers will give 80 participants a single dose of mavoglurant or a placebo and use MRI scans to measure brain responses t…
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Yale researchers scan brains to see how THC impairs memory
Knowledge-focused Recruiting nowThis study looks at how THC, the active ingredient in cannabis, temporarily affects memory, learning, and balance in adults aged 21 to 55 who have used cannabis before. Ten participants will complete memory tasks and balance tests inside an fMRI scanner after taking either THC or…
Phase: PHASE2 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
PET scans reveal Cocaine's brain impact
Knowledge-focused Recruiting nowThis study uses PET scans with a special tracer to measure brain synapse density in 80 people—some with cocaine use disorder and some healthy controls. Researchers aim to see if cocaine changes brain connections, especially in areas linked to decision-making and addiction. Partic…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:42 UTC
-
New brain scans may uncover hidden HIV damage
Knowledge-focused Recruiting nowThis study uses special PET scans to measure brain synapse density in people with HIV who are on effective treatment. Researchers want to understand why some still develop thinking or memory problems. They will compare 70 participants (with and without HIV) over two years using b…
Phase: PHASE1, PHASE2 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:53 UTC